Skip to main content
CivicGate

← Organizations

Tiber Creek Group

lobbying firm

Tiber Creek Group's federal footprint as a lobbying firm — reported lobbying it billed or handled on behalf of the clients it represents (this is the firm's reported revenue for that work, not its own spending). Figures are as reported to the U.S. Senate (LDA).

Lobbying from Senate LDA

Reported lobbying billed / handled $98,815,000
Firm activeFY2022–FY2025

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Tiber Creek Group per filing year
FYLobbying billed / handled (as firm)
2022$25,490,000
2023$24,420,000
2024$24,750,000
2025$24,155,000

Reported lobbying revenue for the clients Tiber Creek Group represents — not the firm's own spending.

Clients represented

  • Discovery Communications, LLC $1,920,000 · 16 filings
  • Phrma $1,880,000 · 18 filings
  • Ickes & Enright Group (Northwell Health Fka North Shore-Lij) $1,760,000 · 16 filings
  • Cigna Corporation And Subsidiaries $1,440,000 · 16 filings
  • Microsoft Corporation $1,440,000 · 16 filings
  • Phlow Corporation $1,420,000 · 16 filings
  • Vertex Pharmaceuticals $1,320,000 · 17 filings
  • Mastercard $1,310,000 · 17 filings
  • Acadia Pharmaceuticals, INC. $1,280,000 · 16 filings
  • Entergy Services LLC $1,280,000 · 16 filings

Clients Tiber Creek Group filed lobbying for, by reported amount billed/handled.

Issues

Issue area Worked
Health Issues 523
Medicare/Medicaid 453
Taxation/Internal Revenue Code 422
Budget/Appropriations 347
Trade (domestic/foreign) 291
Homeland Security 184
Financial Institutions/Investments/Securities 179
Labor Issues/Antitrust/Workplace 175
Environment/Superfund 167
Energy/Nuclear 145
Banking 121
Insurance 121
Defense 117
Communications/Broadcasting/Radio/TV 84
Immigration 83
Copyright/Patent/Trademark 72
Computer Industry 65
Telecommunications 56
Science/Technology 52
Government Issues 50
Small Business 49
Transportation 44
Agriculture 40
Education 40
Manufacturing 38
Consumer Issues/Safety/Products 37
Aviation/Airlines/Airports 29
Foreign Relations 26
Law Enforcement/Crime/Criminal Justice 26
Torts 22

Issue areas across Tiber Creek Group's filings, by activity count. Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

  • FY2025 Homeland Security

    Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.

    H.Con.Res. 14

  • FY2025 Torts

    General litigation reform issues; Third party litigation funding issues; H.R. 1109 - Litigation Transparency Act of 2025.

    H.R. 1109

  • FY2025 Law Enforcement/Crime/Criminal Justice

    General litigation reform issues; Third party litigation funding issues; H.R. 1109 - Litigation Transparency Act of 2025.

    H.R. 1109

  • FY2025 Medicare/Medicaid

    Issues related to Medicare Part D and Part B Pricing Reform.

  • FY2025 Trade (domestic/foreign)

    Issues related to intellectual property protections.

  • FY2025 Health Issues

    Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

  • FY2025 Health Issues

    Issues related to global health policy and funding.

  • FY2025 Budget/Appropriations

    Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026.

    H.R. 4779

Show 52 more activities
  • FY2025 Trade (domestic/foreign)

    Issues related to trade.

  • FY2025 Agriculture

    Issues related to nutrition.

  • FY2025 Environment/Superfund

    Issues related to sustainability.

  • FY2025 Budget/Appropriations

    Issues related to appropriations for fiscal year 2026.

  • FY2025 Education

    Issues related to campus safety.

  • FY2025 Health Issues

    Issues related to global health policy and funding.

  • FY2025 Budget/Appropriations

    Issues related to global health policy and funding.

  • FY2025 Medicare/Medicaid

    Issues related to laboratory services covered under Medicare.

  • FY2025 Health Issues

    Issues related to global health funding and policy; Reauthorization of the President's Emergency Plan for AIDS Relief (PEPFAR).

  • FY2025 Budget/Appropriations

    Issues related to global health funding and policy; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026.

    H.R. 4779

  • FY2025 Health Issues

    Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to oncology; Issues related to ophthalmology; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to the One Big Beautiful Bill Act (PL 119-21).

    H.R. 946 S. 1862

  • FY2025 Medicare/Medicaid

    Issues related to the implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to competition in the travel industry.

  • FY2025 Manufacturing

    Issues related to trade and tariffs.

  • FY2025 Medicare/Medicaid

    Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

    H.R. 946 S. 1862

  • FY2025 Trade (domestic/foreign)

    Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.

    S. 998

  • FY2025 Health Issues

    Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to HIV; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).

  • FY2025 Medicare/Medicaid

    Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).

  • FY2025 Medicare/Medicaid

    Issues related to Medicare Part D drug rebates.

  • FY2025 Telecommunications

    Issues related to next generation wireless communications; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Defense

    Issues related to defense appropriations; Issues related next generation wireless communications.

  • FY2025 Health Issues

    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

  • FY2025 Medicare/Medicaid

    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

  • FY2025 Trade (domestic/foreign)

    Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.

  • FY2025 Medicare/Medicaid

    Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.Con.Res. 14.

    H.Con.Res. 14

  • FY2025 Health Issues

    Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.Con.Res. 14.

    H.Con.Res. 14

  • FY2025 Health Issues

    Issues related to point of care testing; Issues related to Antimicrobial Resistance (AMR).

  • FY2025 Medicare/Medicaid

    Issues related to reimbursement for diagnostic tests.

  • FY2025 Health Issues

    Issues related to domestic pharmaceutical production.

  • FY2025 Banking

    Issues related to Industrial Loan Companies (ILCs) and credit card interchange rates.

  • FY2025 Financial Institutions/Investments/Securities

    Issues related to Industrial Loan Companies (ILCs); H.R. 3881/S. 1838 - Credit Card Competition Act of 2023; Issues related to interchange fees; S. 3538 - Close the Shadow Banking Loophole Act.

    H.R. 3881 S. 1838 S. 3538

  • FY2025 Banking

    Monitoring legislative proposals affecting the regulation of financial services.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to 2025 tax reform; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Housing

    S. 2651 - ROAD to Housing Act of 2025; S. 1527 - Housing Affordability Act.

    S. 2651 S. 1527

  • FY2025 Gaming/Gambling/Casino

    Issues related to the Wire Act (PL 87-216), internet gaming, and online wagering.

  • FY2025 Indian/Native American Affairs

    Issues related to tribal recognition, lands in trust, and tribal sovereignty.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to H.R. 2233 - SLOT Act of 2025.

    H.Con.Res. 14 H.R. 2233

  • FY2025 Real Estate/Land Use/Conservation

    Issues related to S. 1005 - Southern Nevada Economic Development and Conservation Act.

    S. 1005

  • FY2025 Insurance

    Advocating for appropriate tax treatment of reinsurance transactions in the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Taxation/Internal Revenue Code

    Advocating for appropriate tax treatment of reinsurance transactions in the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Financial Institutions/Investments/Securities

    General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery).

  • FY2025 Taxation/Internal Revenue Code

    Issues related to 2025 tax reform; Issues related to the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Medicare/Medicaid

    Issues related to value-based health care; Issues related to reforming physician payments and the Medicare Access and CHIP Reauthorization Act (MACRA) (PL 114-10); Issues related to Medicare Advantage; Issues related to the extension of Alternative Payment Model bonus payments; Issues related to Medicare payment demonstration projects; Issues related to physician payment changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to the continuation of Medicare telehealth flexibilities.

  • FY2025 Computer Industry

    Issues related to AI.

  • FY2025 Health Issues

    Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act.

    S. 3097

  • FY2025 Insurance

    Advocating for appropriate tax treatment of reinsurance transactions in the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Taxation/Internal Revenue Code

    Advocating for appropriate tax treatment of reinsurance transactions in the One Big Beautiful Bill Act (PL 119-21).

  • FY2025 Tariff (miscellaneous tariff bills)

    Issues related to tariffs.

  • FY2025 Health Issues

    Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid.

  • FY2025 Budget/Appropriations

    Issues related to securing federal appropriations in fiscal year 2026 related to environmental clean-up of contaminated buildings within the county; Issues related to appropriations to update the existing sewer lines in Mississippi County; Issues related to upgrades for the Blytheville Aeroplex.

  • FY2025 Homeland Security

    Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.

    H.R. 4213

  • FY2025 Health Issues

    Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to the One Big Beautiful Bill Act (PL 119-21).

    H.R. 946 S. 1862

The specific issues and bills Tiber Creek Group reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.